Media-OutReach Newswire MIPIM Asia Summit 2024: Asia's Leading Platform for Real Estate Investment and Partnerships
Media-OutReach Newswire AIM Vaccine’s heavyweight single-product mRNA RSV Vaccine obtained the clinical trial approval
Media-OutReach Newswire Gold, stocks, and dollar: Octa’s guide to navigating market volatility during election time
Society Low rate of adverse reactions from AstraZeneca COVID shots in Việt Nam, immunisation official says
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 1.
Bora Pharmaceuticals Exits Integration Phase with Sequentially-Improved Gross and Operating Margins 3.